What 2015 Will Bring For Pfizer?

In our opinion, Pfizer is doing the right thing by entering licensing deals pertaining to oncology and investing in new and innovative areas such as gene therapy. If some of these partnerships succeed, its topline can receive a strong boost. We expect Pfizer's growth to remain under pressure in 2015. But at the same time, we believe that the company will be anticipating that some of its investments start to bear fruit. We won't be surprised if it goes for another big acquisition attempt this yea...